Oviva
PrivateLast Round
Series D
Jan 22, 2026
Total Funding Raised
$333.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Oviva operates in Healthcare & Life Sciences and is based in Zurich. Its latest recorded funding round was a Series D round in January 2026.
Oviva is a digital health company that provides personalized diet and lifestyle coaching through a mobile application to help manage weight-related conditions.
Sector
Healthcare & Life Sciences
Verticals
Telemedicine, Patient Engagement, Healthcare Analytics, Sports & Fitness
Business Model
B2B2C
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oviva Comparables
Compare Oviva with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Liva Healthcare | 81% | |
| Second Nature | 81% | |
| Virta Health | 81% |
For institutional investors. Book with your work email.
Oviva Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Jan 22, 2026 | ||||
| Series C | Sep 1, 2021 | ||||
| Series B | Jan 15, 2020 | ||||
| Series A | Nov 20, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oviva Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Partech | Series B, Seed, Series A |
| Temasek | Series D, Series C |
| Planet First Partners | Series D |
| F-Prime Capital | Series C, Series B, Series A |
| Partech | Series B |
| Eight Roads Ventures | Series C, Series B, Series A |
| MTIP | Series C, Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 18, 2026
Supported over one million people across UK, Switzerland, and Germany.
- Jan 22, 2026
$220M Series D round completed.
For institutional investors. Book with your work email.
Oviva Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oviva's valuation, stock price, and market status.
Is Oviva a public or private company?
Oviva is a private company.
What is the current stock price of Oviva?
Oviva is a private company, so its shares have no public market price. Caplight tracks Oviva's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oviva worth (valuation)?
Valuation information for Oviva is not publicly available.
Can I buy Oviva stock?
Oviva shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oviva's last funding round?
Oviva's most recent funding round was Series D on January 22, 2026.
Who are the main investors in Oviva?
Key investors in Oviva include Partech, Temasek, MTIP, Earlybird Venture Capital, Sofina.
Will Oviva IPO soon?
No public IPO plans have been announced for Oviva.
How can I track Oviva secondary market activity?
Caplight tracks bids, offers, and trades in Oviva's shares on secondary markets.